Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • nct (1)
Country
  • Austria (1)
  • Belgium (1)
  • France (1)
  • India (1)
  • Italy (1)
  • Poland (1)
  • Portugal (1)
  • Russian Federation (1)
  • Serbia (1)
  • Sweden (1)
  • Ukraine (1)
  • United Kingdom (1)
  • United States (1)
Source
  • nct (1)
Phase
  • ongoing (1)

Country: United Kingdom,France,Ukraine,Portugal,Russian Federation,Italy,India,Austria
nct Update Il y a 5 ans

A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis To assess the long-term safety and tolerability of ACP-103 in subjects with Parkinson's disease psychosis.

  • Country Austria, Belgium, France, India, Italy, Poland, Portugal, Russian Federation, Serbia, Sweden, Ukraine, United Kingdom, United States,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.